Who are Administration of Albendazole on Day 1's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): albendazole and praziquantel, Docetaxel or albumin paclitaxel, Placebo plus Docetaxel, Albendazole plus Praziquantel, Standard of Care: Docetaxel, ZENTEL and Vitamin A Soft Capsules.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/administration-of-albendazole-on-day-1.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Administration of Albendazole on Day 1 — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Administration of Albendazole on Day 1 (Administration of Albendazole on Day 1) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Benzimidazole anthelmintic. Area: Infectious Disease / Parasitology.

marketed Benzimidazole anthelmintic β-tubulin Infectious Disease / Parasitology Small molecule Live · refreshed every 30 min

Target snapshot

Administration of Albendazole on Day 1 (Administration of Albendazole on Day 1) — London School of Hygiene and Tropical Medicine. Albendazole inhibits microtubule polymerization in parasitic worms by binding to β-tubulin, disrupting their cellular structure and causing paralysis and death.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Administration of Albendazole on Day 1 TARGET	Administration of Albendazole on Day 1	London School of Hygiene and Tropical Medicine	marketed	Benzimidazole anthelmintic	β-tubulin
albendazole and praziquantel	albendazole and praziquantel	R-Evolution Worldwide S.r.l. Impresa Sociale	marketed	Anthelmintic combination	β-tubulin (albendazole); calcium channels (praziquantel)
Docetaxel or albumin paclitaxel	Docetaxel or albumin paclitaxel	Shandong Cancer Hospital and Institute	marketed	Taxane; microtubule-stabilizing chemotherapy agent	β-tubulin (microtubule)
Placebo plus Docetaxel	Placebo plus Docetaxel	Infinity Pharmaceuticals, Inc.	marketed	Taxane (microtubule stabilizer)	Microtubules (β-tubulin)
Albendazole plus Praziquantel	Albendazole plus Praziquantel	Navrongo Health Research Centre, Ghana	marketed	Antihelmintic combination	β-tubulin (albendazole); calcium channels (praziquantel)
Standard of Care: Docetaxel	Standard of Care: Docetaxel	H. Lee Moffitt Cancer Center and Research Institute	marketed	Taxane; microtubule stabilizer	β-tubulin
ZENTEL and Vitamin A Soft Capsules	ZENTEL and Vitamin A Soft Capsules	Chengdu Maternal and Children's Health Care Hospital	marketed	Anthelmintic + Vitamin supplement	β-tubulin (albendazole component)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Benzimidazole anthelmintic class)

Lihir Medical Centre · 1 drug in this class
London School of Hygiene and Tropical Medicine · 1 drug in this class
Universidad Nacional de Salta · 1 drug in this class
University of Kelaniya · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Administration of Albendazole on Day 1 — Competitive Intelligence Brief. https://druglandscape.com/ci/administration-of-albendazole-on-day-1. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab